Manjusha Joshi
Corporate Officer/Principal at SAI Life Sciences Ltd.
Profile
Manjusha Joshi is currently working as the Vice President-Formulations at SAI Life Sciences Ltd.
She previously worked as the Vice President at Emcure Pharmaceuticals Ltd.
She is a graduate from the University of Pune.
Manjusha Joshi active positions
| Companies | Position | Start |
|---|---|---|
SAI Life Sciences Ltd.
 SAI Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology SAI Life Sciences Ltd. manufactures, develops, and discovers pharmaceutical drugs. The company was founded in 1999 and is headquartered in Hyderabad, India. | Corporate Officer/Principal | - |
Former positions of Manjusha Joshi
| Companies | Position | End |
|---|---|---|
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Corporate Officer/Principal | - |
Training of Manjusha Joshi
| University of Pune | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
SAI Life Sciences Ltd.
SAI Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology SAI Life Sciences Ltd. manufactures, develops, and discovers pharmaceutical drugs. The company was founded in 1999 and is headquartered in Hyderabad, India. | Health Technology |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Stock Market
- Insiders
- Manjusha Joshi
